Despite continued challenges, ESCO reported a strong Q4 and is optimistic about fiscal 2022. A&D sales declined 16%, but USG and Test grew 16% and 11%, respectively. Orders in all three segments also showed promising growth, with A&D orders up 25%, USG orders up 8% (excluding acquisitions), and Test orders increasing by 33%. Adjusted EBIT margins improved compared to Q3, and the company generated strong cash flow. For fiscal 2022, ESCO forecasts sales growth of 13-16% with A&D expected to grow 10-12%, USG 28-32%, and Test 3-5%. Despite headwinds such as increased interest expense and higher tax rates, the company anticipates adjusted EPS growth of 20-24% to a range of $310 million to $320 million.